fosinopril sodium and hydrochlorothiazide
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (fosinopril sodium and hydrochlorothiazide) by Gen Pharmaceuticals is mechanism of action fosinopril and fosinoprilat inhibit angiotensin-converting enzyme (ace) in human subjects and in animals. Approved for hypertension. First approved in 2009.
Drug data last refreshed Yesterday
Mechanism of Action Fosinopril and fosinoprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and in animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone…
Thiazide Diuretic
Worked on FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.